Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors


Arga M., Oguz A., PINARLI F. G. , KARADENİZ C. , Citak E. C. , Emeksiz H. C. , ...More

PEDIATRICS INTERNATIONAL, vol.57, no.3, pp.406-413, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 57 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1111/ped.12542
  • Title of Journal : PEDIATRICS INTERNATIONAL
  • Page Numbers: pp.406-413

Abstract

BackgroundThe aim of this study was to compare the nephrotoxicity risk of cisplatin (CPL) and ifosfamide (IFO) combination treatment (CT) with that of CPL alone and to evaluate the prevalence of CPL-induced long-term nephrotoxicity in pediatric cancer survivors (CS).